• SENSEX 82,500.47
    -689.81 (--0.83%)
  • BANKNIFTY 56,754.70
    -201.30 (--0.35%)
  • Enviro Infra
    284.00 392.00(%)
  • Mamata Machinery
    525.00 649.00(%)
  • Glenmark Pharma.
    2,286.15 2,286.15(%)
  • Crizac
    364.00 364.00(%)
  • TCS
    3,261.35 3,060.25(%)
  • Eternal Ltd
    264.90 304.50(%)
  • Hind. Unilever
    2,530.00 3,034.50(%)
  • JP Power Ven.
    24.86 24.86(%)
  • Indian Renewable
    159.05 137.00(%)
  • Tata Elxsi
    5,679.00 4,601.05(%)
  • Infosys
    1,563.25 1,307.10(%)
  • Netweb Technol.
    1,989.00 3,060.00(%)
  • Reliance Industr
    1,490.10 1,115.55(%)
  • RattanIndia Pow.
    15.90 8.44(%)
  • Meta Infotech
    236.25 236.25(%)
  • Interglobe Aviat
    5,937.00 6,019.20(%)
  • Quality Power El
    760.90 270.60(%)
  • Bharat Electron
    404.95 240.15(%)
  • ICICI Bank
    1,414.55 1,153.30(%)
  • Kirloskar Oil
    895.60 544.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Mercury Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 2899.0
  • ISIN : INE947G01011
891.15 40 (4.72%)
  • As on 11 Jul 2025 (EOD)

  • Today’s Low

    871.00

  • Today’s High

    893.90

  • Open

    888.90

  • Perv Close

    851.00

  • 52W Low

    736.00

  • 52W High

    1,190.00

Key Indicators

  • P/E(TTM)

    34.00

  • Mar.Cap (₹Cr.)

    106.94

  • Div & Yield %

    0.39

  • Book Value(₹)

    446.42

  • Debt-Equity Ratio

    4.72

  • AGM Date

    11-Jul-2025

  • EPS

    26.21

  • P/E Ratio

    34.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    106.94

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    1.20

  • BV (₹)

    446.40

  • Sales( ₹ in Cr.)

    75.10

  • NP (in Cr.)

    3.14

  • NP Var(%)

    -44.0

  • Div%

    35.0

  • CPS (₹)

    50.20

  • EPS (₹)

    26.20

  • Traded Value (₹ in Lakhs)

    106.94

  • 52 Week High

    1,190.00

  • 52 Week Low

    736.00

  • Price BSE

    891.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    106.94

  • P/C Ratio

    17.80

  • P/E Ratio

    34.00

  • Price Vs.BV

    26.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 75.56 75.33 57.92 68.60 57.27 55.52
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 75.56 75.33 57.92 68.60 57.27 55.52
Other Income 1.09 1.72 0.94 0.88 0.85 1.04
Stock Adjustments 0.15 0.55 0.22 -0.16 -0.84 -1.75
Total Income 76.80 77.60 59.08 69.32 57.28 54.81
EXPENDITURE :            
Raw Materials 30.45 30.96 23.88 31.01 24.80 24.59
Power and Fuel Cost 1.87 1.62 1.15 1.59 1.62 1.31
Employee Cost 14.50 14.24 12.50 9.80 9.30 7.83
Other Manufacturing Expenses 2.79 2.84 1.43 1.46 1.38 1.76
Selling and Administration Expenses 14.56 15.53 11.75 12.40 12.12 12.02
Miscellaneous Expenses 2.50 2.11 0.45 2.59 1.05 0.54
Employee Benefit Expenses 14.50 14.24 12.50 9.80 9.30 7.83
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 66.68 67.31 51.15 58.85 50.26 48.05
Operating Profit 10.12 10.29 7.94 10.47 7.02 6.77
Interest 0.38 0.36 0.45 0.64 0.82 1.09
Gross Profit 9.74 9.93 7.49 9.83 6.20 5.68
Depreciation 2.82 2.48 2.45 1.92 1.87 1.63
Profit Before Tax 6.92 7.45 5.04 7.91 4.33 4.05
Current Tax 1.90 2.20 1.37 2.18 1.18 0.98
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.63 -0.34 0.10 0.39 -0.08 0.23
Reported Net Profit 5.65 5.58 3.56 5.34 3.23 2.84
Extraordinary Items 0.05 -0.02 0.11 0.00 0.00 0.00
Adjusted Net Profit 5.60 5.60 3.45 5.34 3.23 2.84
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 4.20 2.54 2.72 1.50 0.99 0.37
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 3.92 3.92 3.74 3.92 2.72 2.22
P & L Balance carried down 5.93 4.20 2.54 2.92 1.50 0.99
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 35.00 35.00 35.00 35.00 20.00 15.00
Dividend Per Share(Rs) 3.50 3.50 3.50 3.50 2.00 1.50
Earnings Per Share-Unit Curr 47.12 46.49 29.68 44.48 26.90 23.63
Earnings Per Share(Adj)-Unit Curr 47.12 46.49 29.68 44.48 26.90 23.63
Book Value 423.65 380.24 335.89 307.45 266.48 241.38
Book Value(Adj)-Unit Curr 423.65 380.24 335.89 307.45 266.48 241.38

Shareholding Pattern

  • Promoter Group

    73.66%

  • Public Share Holding

    26.34%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 883,900 73.66 883,900 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 883,900 73.66 883,900 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 8,226 0.69 7,426 9
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 25,936 2.16 14,736 24
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 6,458 0.54 6,258 40
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 26,390 2.20 26,390 1
Individuals holding nominal share capital up to Rs. 1 lakh 173,531 14.46 129,831 1,308
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 75,500 6.29 75,500 1
Sub Total 316,100 26.34 260,200 1,386
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 1,200,000 100.00 1,144,100 1,397

Company Background

Mercury Laboratories LtdPharmaceuticals - Indian - Formulations

  • Mercury Laboratories Ltd
  • BSE Code : 2899.0
  • ISIN : INE947G01011

  • Incorporation Year

    1982

  • Registered Office

    1st Floor 18 Shreeji Bhuwan 51
    Princess Street Mangaladas Rd, Mumbai,
    Maharashtra-400002

  • Telephone

    91-22-66372841

  • FAX

    91-22-22015441

  • Chairman

    SANJAY SHANTILAL PATEL

  • Managing Director

    Rajendra R Shah

  • Company Secretary

  • Auditor

    Naresh & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Link Intime India Pvt Ltd
    B-102&103 Shangrila,
    Complex First Floor,Akota
    Mumbai - Vadodara - 390 020

Mercury Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Mercury Labs 891.15 76.65 75.56 34.00 13.54
Abbott India 34,409.95 6,097.18 5,848.91 51.70 44.71
Astrazeneca Phar 9,237.05 1,330.33 1,295.53 199.50 33.26
P & G Health Ltd 5,777.05 1,166.89 1,151.26 38.18 39.76
Glaxosmi. Pharma 3,242.30 3,866.05 3,723.49 59.77 58.72
Cipla 1,485.05 20,029.57 19,044.85 23.25 21.40
Amrutanjan Healt 726.25 437.58 421.23 41.31 20.84
Fermenta Biotec. 384.45 315.24 307.09 16.74 4.10
Guj. Themis Bio. 343.55 174.19 169.82 76.69 44.82
Bliss GVS Pharma 153.75 703.42 667.20 23.51 9.16
Ambalal Sarabhai 36.16 19.33 4.04 33.48 2.10